Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R44 HL58285, R41 HL80886, R41 HL084795, RO1 HL63340)
Received: 15 December 2017
Accepted: 23 January 2018
First Online: 16 March 2018
Ethics approval and consent to participate
: The study protocol was approved by the Institutional Animal Care and Use Committee at the University of Alabama at Birmingham and complied with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health).
: Not applicable.
: Dr. Schoepf receives institutional research support from Astellas, Bayer Healthcare, General Electric Healthcare, and Siemens Healthineers. Dr. Varga-Szemes receives institutional research support from Siemens Healthineers. Dr. Schoepf has received consulting or speaking fees from Bayer, Guerbet, HeartFlow, and Siemens Healthineers. The other authors have no competing interests to disclose.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.